Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Approvals
Bioiberica Obtains Approval For Its Chondroitin Sulfate As An Ethical Drug In Osteoarthritis In Five More European Countries 3/5/2015 11:30:00 AM
Bristol-Myers Squibb (BMY) Grabs Record Fast Approval for Opdivo 3/5/2015 6:34:48 AM
Pfizer (PFE) Receives European Approval For New Indication For Prevenar 13 For Prevention Of Vaccine-Type Pneumococcal Pneumonia In Adults 3/3/2015 10:37:27 AM
Actavis (ACT) Hormonal Contraceptive Device Wins FDA Approval 3/2/2015 6:36:10 AM
Actavis (ACT) Receives Approval From The European Commission For XYDALBA (dalbavancin) 3/2/2015 7:37:08 AM
Sanofi (SAN.PA) Wins FDA Approval for New Insulin Drug Toujeo 2/26/2015 5:59:37 AM
Otsuka Pharmaceutical Co., Ltd. Release: First-Ever Treatment Approved In Canada For Adults Living With ADPKD, A Life-Threatening Kidney Disease 2/27/2015 6:47:35 AM
Actavis (ACT) And Medicines360 Announce FDA Approval Of LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 Mg To Prevent Pregnancy For Up To Three Years 2/27/2015 6:46:23 AM
23andMe Wins FDA Approval for First Genetic Test Kit 2/20/2015 6:05:41 AM
Sanofi (SAN.PA) Receives FDA Approval Of Once-Daily Basal Insulin Toujeo 2/26/2015 6:02:59 AM
Zambon Release: Parkinson’s Disease (PD): EU Commission Approves Xadago (Safinamide) For Mid-Late Stage PD Patients 2/26/2015 11:02:41 AM
Actavis (ACT) Receives U.S. FDA Approval For AVYCAZ (CEFTAZIDIME-AVIBACTAM) 2/26/2015 6:48:51 AM
Novartis AG (NVS)'s Farydak Wins FDA Approval After Setback 2/24/2015 6:08:48 AM
Novartis AG (NVS) Receives FDA Approval Of Farydak, The First HDAC Inhibitor For Patients With Multiple Myeloma 2/24/2015 6:09:38 AM
MEDA: Dymista Approved In Children 6 To 11 Years Of Age With Seasonal Allergic Rhinitis 2/23/2015 11:54:19 AM
1234567
//-->